KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hologic (HOLX) Operating Expenses (2016 - 2025)

Hologic (HOLX) has disclosed Operating Expenses for 17 consecutive years, with $349.4 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses changed 0.37% to $349.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 5.71% year-over-year, with the annual reading at $1.4 billion for FY2025, 4.34% up from the prior year.
  • Operating Expenses hit $349.4 million in Q4 2025 for Hologic, up from $346.6 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $388.6 million in Q3 2021 to a low of $285.9 million in Q2 2022.
  • Historically, Operating Expenses has averaged $344.0 million across 5 years, with a median of $348.0 million in 2025.
  • Biggest five-year swings in Operating Expenses: grew 29.97% in 2021 and later dropped 16.65% in 2022.
  • Year by year, Operating Expenses stood at $345.0 million in 2021, then rose by 3.04% to $355.5 million in 2022, then increased by 3.88% to $369.3 million in 2023, then decreased by 5.04% to $350.7 million in 2024, then decreased by 0.37% to $349.4 million in 2025.
  • Business Quant data shows Operating Expenses for HOLX at $349.4 million in Q4 2025, $346.6 million in Q3 2025, and $322.0 million in Q2 2025.